Clinical trial
A Multi-Center Open-label Investigation to Assess the Safety and Efficacy of Multiple Doses of DM199 in Patients With Chronic Kidney Disease
NCT04123613 is registered in ClinicalTrials.gov with DiaMedica Therapeutics Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center Open-label Investigation to Assess the Safety and Efficacy of Multiple Doses of DM199 in Patients With Chronic Kidney Disease
- Lead sponsor
- DiaMedica Therapeutics Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 17, 2019
- Completion date
- March 16, 2022
- Enrollment
- 79 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.